• Go to the menu
  • Go to content
Bioregate Logo RFI
Rechercher
My accountLogin
  • fr
  • en
Contact Donate
Menu
  • Bioregate
    • Missions
    • Consortium
    • Organization
    • Operational team
    • Regional skills overview
  • Skills
    • Players Network
      • Research laboratories
      • Technology platforms
      • Clinical Innovation
      • Companies
    • Innovation supports
  • Projects
    • Research projects
    • Clinical trials
    • R&D projects
    • Publications
  • Education & Training
  • Partnerships
  • Agenda & News
  • Calls for projects
  • Bioregate Forum
    • 2016 Edition
    • 2018 Edition
  1. Home
  2. Regenerative Medicine

17 November 2017

Adhesion, proliferation and osteogenic differentiation of human MSCs cultured under perfusion with a marine oxygen carrier on an allogenic bone substitute.

Tissue engineering strategies have been developed to optimize osseointegration in dental implant surgery. One of

Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Read more

17 November 2017

Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.

he aim of this study was the evaluation of the safety and efficacy of unilateral

Regenerative Medicine
Research
Read more

17 November 2017

Pullulan microbeads/Si-HPMC hydrogel injectable system for the sustained delivery of GDF-5 and TGF-β1: new insight into intervertebral disc regenerative medicine.

Discogenic low back pain is considered a major health concern and no etiological treatments are

Repair medicine
Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Read more

17 November 2017

Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates

Recombinant adeno-associated virus (AAV) has emerged as a promising vector for retinal gene delivery to

Regenerative Medicine
Research
Read more

17 November 2017

Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates

No treatment is available for early-onset forms of metachromatic leukodystrophy (MLD), a lysosomal storage disease

Regenerative Medicine
Research
Read more

15 November 2017

Atlantic Ket Med, a new European project involving Bioregate

Altantic Ket Med – AKM – is a European project aiming at enhancing innovation capacity

Repair medicine
Regenerative Medicine
Education
Innovation
Read more

Previous page 1 … 9 10 11 12 13 … 17 Next page
Back to top
  • Logo RFI
  • Bioregate
  • Contact
  • Terms and conditions
  • Site map

Led by

  • Université - Nantes

Funded by

In partnership with

  • logo-lemans-universite
  • Atlanpole-Biotherapies
© 2026 Bioregate All rights reserved.